CS Medica Income Statement

Financials in millions DKK. Fiscal year is October - September.

Millions DKK. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019
Revenue	4.67	1.07	10.58	3.18	2.11	1.43
Revenue Growth (YoY)	-54.48%	-89.92%	232.85%	50.64%	48.02%	-
Cost of Revenue	2.85	0.15	5.96	1.5	1.43	1.21
Gross Profit	1.81	0.91	4.62	1.68	0.68	0.21
Selling, General & Admin	14.06	16.9	16.62	2.47	0.91	-
Other Operating Expenses	-0.04	-0.16	-0.74	-1.99	-0.68	-
Operating Expenses	16.1	18.81	17.95	1.85	0.62	0.02
Operating Income	-14.28	-17.9	-13.33	-0.18	0.07	0.19
Interest Expense	-1.32	-0.57	-0.83	-0.23	-0.14	-0.14
Other Non Operating Income (Expenses)	-	0	-0	-0	0	0
Pretax Income	-16.06	-18.47	-14.16	-0.41	-0.08	0.05
Income Tax Expense	-3.75	-3.95	-3.36	-1.06	-0.02	0.17
Net Income	-12.31	-14.51	-10.8	0.65	-0.05	-0.12
Net Income to Common	-12.31	-14.51	-10.8	0.65	-0.05	-0.12
Shares Outstanding (Basic)	12	12	12	5	-	-
Shares Outstanding (Diluted)	12	12	12	5	-	-
Shares Change (YoY)	-2.22%	6.12%	113.03%	-	-	-
EPS (Basic)	-1.00	-1.18	-0.93	0.12	-	-
EPS (Diluted)	-1.00	-1.18	-0.93	0.12	-	-
Free Cash Flow	-0.05	-8.33	-14.04	-6.02	0.67	1.13
Free Cash Flow Per Share	-0.00	-0.68	-1.21	-1.10	-	-
Gross Margin	38.81%	85.60%	43.66%	52.72%	32.34%	14.81%
Operating Margin	-306.15%	-1677.04%	-125.99%	-5.54%	3.12%	13.09%
Profit Margin	-263.84%	-1359.80%	-102.08%	20.37%	-2.59%	-8.35%
Free Cash Flow Margin	-1.09%	-780.39%	-132.68%	-189.30%	31.58%	79.23%
EBITDA	-13.81	-17.42	-12.86	0.18	0.45	0.21
EBITDA Margin	-295.89%	-	-121.47%	5.65%	21.34%	14.81%
D&A For EBITDA	0.48	0.48	0.48	0.36	0.38	0.02
EBIT	-14.28	-17.9	-13.33	-0.18	0.07	0.19
EBIT Margin	-	-	-125.99%	-5.54%	3.12%	13.09%
Effective Tax Rate	-	-	-	-	-	345.50%

Source: S&P Capital IQ. Standard template. Financial Sources.